HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults

被引:9
作者
Matthews, Philippa C. [1 ,3 ]
Carlson, Jonathan M. [9 ]
Beloukas, Apostolos [5 ]
Malik, Amna [2 ]
Jooste, Pieter [13 ]
Ogwu, Anthony [10 ,16 ]
Shapiro, Roger [10 ,16 ]
Riddell, Lynn [6 ]
Chen, Fabian [7 ]
Luzzi, Graz [8 ]
Jesuthasan, Gerald [3 ]
Jeffery, Katie [3 ]
Jojic, Nebojsa [9 ]
Ndung'u, Thumbi [11 ,14 ,15 ,17 ]
Carrington, Mary [11 ,12 ]
Goulder, Philip J. R. [2 ,14 ]
Geretti, Anna Maria [5 ]
Klenerman, Paul [1 ,3 ,4 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford, England
[2] Univ Oxford, Dept Pediat, Oxford, England
[3] Oxford Univ Hosp NHS Trust, Dept Infect Dis & Microbiol, Oxford, England
[4] John Radcliffe Hosp, NIHR Biomed Res Ctr, Oxford OX3 9DU, England
[5] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Cliftonville, England
[6] Northampton Gen Hosp, Integrated Sexual Hlth Serv, Cliftonville, England
[7] Royal Berkshire Hosp, Dept Sexual Hlth, Reading RG1 5AN, Berks, England
[8] High Wycombe Hosp, Dept Sexual Hlth, Wycombe, Bucks, England
[9] ESci Grp, Microsoft Res, Redmond, WA USA
[10] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA
[11] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA
[12] Frederick Natl Lab Canc Res, Leidos Biomed Res, Expt Immunol Lab, Canc & Inflammat Program, College Pk, MD USA
[13] Kimberley Hosp, Dept Pediat, Northern Cape, South Africa
[14] Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa
[15] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Potchefstroom, South Africa
[16] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana
[17] Max Planck Inst Infect Biol, Berlin, Germany
基金
英国惠康基金; 美国国家卫生研究院;
关键词
HBV; HIV; coinfection; immunology; CD8+T cells; HLA; HBeAg (hepatitis B e antigen); viral hepatitis; Africa; VIRUS INFECTION; ASSOCIATION; SELECTION;
D O I
10.1093/infdis/jiv592
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Outcomes of chronic infection with hepatitis B virus (HBV) are varied, with increased morbidity reported in the context of human immunodeficiency virus (HIV) coinfection. The factors driving different outcomes are not well understood, but there is increasing interest in an HLA class I effect. We therefore studied the influence of HLA class I on HBV in an African HIV-positive cohort. We demonstrated that virologic markers of HBV disease activity (hepatitis B e antigen status or HBV DNA level) are associated with HLA-A genotype. This finding supports the role of the CD8(+) T-cell response in HBV control, and potentially informs future therapeutic T-cell vaccine strategies.
引用
收藏
页码:1248 / 1252
页数:5
相关论文
共 50 条
  • [41] Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis:a systematic review and meta-analysis
    Sirio Fiorino
    Maria Letizia Bacchi-Reggiani
    Paolo Leandri
    Elisabetta Loggi
    Pietro Andreone
    World Journal of Hepatology, 2017, (06) : 333 - 342
  • [42] Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran
    Zahedi, Mohammad Javad
    Moghaddam, Sodaif Darvish
    Abasi, Mehdi Hayatbakhsh
    Parnian, Maryam
    Shokoohi, Mostafa
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2014, 64 (02) : 134 - 137
  • [43] Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection
    Aldersley, Jordan
    Lorenz, David R.
    Misra, Vikas
    Uno, Hajime
    Gabuzda, Dana
    AIDS, 2019, 33 (01) : 145 - 152
  • [44] Association between liver fibrosis and hepatitis E seroprevalence among HIV-positive individuals in Nepal
    Shah, Shemal M.
    Baniya, Jagat B.
    Gupta, Birendra Prasad
    Shrestha, Ananta
    Rodin, Holly
    Boonstra, Andre
    Debes, Jose D.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) : 503 - 505
  • [45] Seroprevalence and associated factors of hepatitis B virus infection among HIV-positive adults attending an antiretroviral treatment clinic at Wolaita Sodo University Referral Hospital
    Goa, Abraham
    Dana, Tadele
    Bitew, Shimelash
    Arba, Aseb
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2019, 11 : 137 - 147
  • [46] NUTRITIONAL STATUS, MORPHOLOGICAL AND BIOCHEMICAL BLOOD PARAMETERS IN HIV-POSITIVE ADULTS FROM NORTHERN POLAND
    Lebiedzinska, Anna
    Majewski, Michal
    Waszkiewicz, Martyna
    Maksymowicz-Jaroszuk, Joanna
    Grzeszczuk, Anna
    Bierzynska, Natalia
    Lemanska, Malgorzata
    Jankowska, Maria
    Smiatacz, Tomasz
    Szefer, Piotr
    Karczewski, Jan K.
    JOURNAL OF ELEMENTOLOGY, 2018, 23 (03): : 927 - 946
  • [47] Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
    Jooste, Pieter
    van Zyl, Anriette
    Adland, Emily
    Daniels, Samantha
    Hattingh, Louise
    Brits, Alethea
    Wareing, Susan
    Goedhals, Dominique
    Jeffery, Katie
    Andersson, Monique
    Goulder, Philip
    Matthews, Philippa C.
    JOURNAL OF CLINICAL VIROLOGY, 2016, 85 : 71 - 74
  • [48] Risk Factors for Drinking among HIV-Positive African American Adults: The Depression-Gender Interaction
    Longmire-Avital, Buffie
    Holder, Catherine A.
    Golub, Sarit A.
    Parsons, Jeffrey T.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2012, 38 (03) : 260 - 266
  • [49] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir
    Gish, Robert G.
    Chang, Ting-Tsung
    Lai, Ching-Lung
    de Man, Robert A.
    Gadano, Adrian
    Llamoso, Cyril
    Tang, Hong
    ANTIVIRAL THERAPY, 2013, 18 (05) : 691 - 698
  • [50] Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive
    Shin, Jung Woo
    Park, Neung Hwa
    Jung, Seok Won
    Kim, Byung Chul
    Kwon, Sung Ho
    Park, Jae Serk
    Jeong, In Du
    Bang, Sung-Jo
    Kim, Do Ha
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (41) : 6693 - 6698